Aspire Private Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-220
Closed -$26.2K 472
2024
Q3
$26.2K Hold
220
0.01% 283
2024
Q2
$31.4K Buy
220
+1
+0.5% +$133 0.01% 274
2024
Q1
$28.1K Buy
219
+24
+12% +$2.86K 0.01% 283
2023
Q4
$20.2K Sell
195
-15
-7% -$1.48K 0.01% 314
2023
Q3
$19.1K Sell
210
-2
-0.9% -$176 0.01% 317
2023
Q2
$17.2K Sell
212
-6
-3% -$490 0.01% 311
2023
Q1
$17.3K Buy
218
+10
+5% +$709 0.01% 303
2022
Q4
$14.1K Hold
208
0.01% 321
2022
Q3
$10K Sell
208
-8
-4% -$429 ﹤0.01% 348
2022
Q2
$12K Hold
216
﹤0.01% 329
2022
Q1
$12K Buy
216
+60
+38% +$3.08K ﹤0.01% 331
2021
Q4
$9K Buy
156
+32
+26% +$1.73K ﹤0.01% 352
2021
Q3
$6K Hold
124
﹤0.01% 361
2021
Q2
$5K Sell
124
-4
-3% -$155 ﹤0.01% 393
2021
Q1
$4K Buy
128
+120
+1,500% +$4.27K ﹤0.01% 411
2020
Q4
$0 Buy
8
+2
+33% +$69 ﹤0.01% 507
2020
Q3
$0 Sell
6
-126
-95% -$4.2K ﹤0.01% 496
2020
Q2
$4K Buy
132
+124
+1,550% +$3.96K ﹤0.01% 240
2020
Q1
$0 Sell
8
-20
-71% -$596 ﹤0.01% 408
2019
Q4
$1K Buy
+28
New +$775 ﹤0.01% 446

Other funds holding NVO

Aspire Private Capital's NVO Position: Q4 2024 in Review

Aspire Private Capital sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 220 shares — an estimated $26.2K sold.

Aspire Private Capital first reported a position in NVO in Q4 2019 and held it in 20 quarters. The position peaked at $31.4K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Aspire Private Capital reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 220 Novo Nordisk shares in Q4 2024, an estimated $26.2K.
  • Aspire Private Capital first reported a position in Novo Nordisk in Q4 2019 and held it in 20 quarters.
  • Aspire Private Capital's Novo Nordisk position peaked at $31.4K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.